Given the role of COPB2 in apoptosis signaling, as shown by our experiments (see Figure 5), we suspect that the simultaneous inhibition of COPB2 and KRAS in pancreatic cancer cells will be more effective than COPB2 silencing alone. This evidence concerns the gene COPB2 and familial pancreatic carcinoma.